A lower assay signal can reflect slower growth, fewer cells or changed metabolism. Measuring cell death requires evidence suited to that question.
A primary high-content assay study compared direct cell counts with ATP- and metabolism-based measurements and found mechanism-dependent discrepancies. Cell-cycle arrest could change ATP per cell and distort apparent potency. Time-dependent population measurements also distinguish growth behavior from a single endpoint. A result reported as reduced viability should retain its readout, baseline and timing rather than being automatically described as tumor-cell killing.
Shares Growth-rate correction in drug-response assays, Drug response and drug sensitivity (IC50, AUC), Evidence from measurement to patient benefit.
Shares Cell composition confound (tumour versus stroma and immune cells), Drug response and drug sensitivity (IC50, AUC), Evidence from measurement to patient benefit.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/